Portal de Periódicos da CAPES

The “safe” blood donor and the national blood supply: is there a new interface?

1998; Wiley; Volume: 38; Issue: 4 Linguagem: Inglês

10.1046/j.1537-2995.1998.38498257368.x

1537-2995

Edward J. Davey,

Blood transfusion and management

TransfusionVolume 38, Issue 4 p. 323-326 Free Access The "safe" blood donor and the national blood supply: is there a new interface? Edward J. Davey MD, Edward J. Davey MD Chief Medical Officer American Red Cross Biomedical Services Rosslyn, VASearch for more papers by this author Edward J. Davey MD, Edward J. Davey MD Chief Medical Officer American Red Cross Biomedical Services Rosslyn, VASearch for more papers by this author First published: 19 December 2002 https://doi.org/10.1046/j.1537-2995.1998.38498257368.xCitations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Thomson RA, Bethel J, Lo Ay et al. Retention of "safe" blood donors. Transfusion 1998; 38: 359–67. 2 Glynn SA, Schreiber GB, Busch MP et al. Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. Transfusion 1998; 38: 350–8. 3 Liu TC, Kuperan P, Tan C, et al. Structuring a safer donor-replacement program. Transfusion 1998; 38: 368–72. 4 Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: 1685–90. 5 Blood supply: transfusion-associated risks. Report to the ranking minority member, Committee on Commerce, House of Representatives. GAO Publication GAO/PEMD-97-2, February 1997. 6 Sloand EM, Pitt E, Klein HG. Safety of the blood supply. JAMA 1995; 274: 1368–73. 7 AuBuchon JP, Birkmeyer JD, Busch MP. Cost-effectiveness of expanded human immunodeficiency virus testing protocols for donated blood. Transfusion 1997; 37: 45–51. 8 Busch MP, Alter HJ. Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost? (editorial) Transfusion 1995; 35: 536–9. 9 Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA 1997; 277: 967–72. 10 Dodd RY, Sullivan MT. Creutzfeldt-Jakob disease and transfusion safety: tilting at icebergs? (editorial). Transfusion 1998; 38: 221–2. 11 Holman RC, Khan AS, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States, 1979–1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis 1996; 2: 333–7. 12 Read EJ, Herron RM, Hughes DM. Effect of non-monetary incentives on safety of blood donations (abstract). Transfusion 1993; 33(Suppl): 45S. 13 Strauss RG, Ludwig GA, Smith MV, et al. Concurrent comparison of the safety of paid cytapheresis and volunteer whole-blood donors. Transfusion 1994; 34: 116–21. 14 Huestis DW, Taswell HF. Donors and dollars (editorial). Transfuion 1994; 34: 96–7. Citing Literature Volume38, Issue4April 1998Pages 323-326 ReferencesRelatedInformation